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Monoclonal antibody 2D7.10 recognized an antigen present in seven of nine isolates of axenically cultured
Entamoeba histolytica and absent in all other Entamoeba isolates studied. The antigen was absent in two
isolates: 200:NIH and Rahman. All nine isolates belonged to pathogenic zymodeme II. Western blot
(immunoblot) analysis and treatment with periodate and the proteolytic enzyme trypsin suggest that the antigen
recognized by 2D7.10 is a carbohydrate moiety.
Entamoeba histolytica has been shown to have a number
of antigenic determinants both on the cell surface and
intracellularly (3-5, 13, 17, 23, 26). Some of these antigens
have been implicated in cytopathic killing by E. histolytica
(2, 23). Though antigens specific for E. histolytica have been
shown before, isolate-specific antigens have not yet been
characterized. In order to analyze the molecular complexity
of E. histolytica, we generated hybridoma antibodies to
strain HM-1:IMSS, which belongs to a pathogenic zymo-
deme (25). In this report, we describe some of the charac-
teristics of one of the monoclonal antibodies which recog-
nizes an antigen that is present in only some isolates of E.
histolytica and absent in all other Entamoeba isolates tested.
The Entamoeba strains and species used in this study are
described in Table 1. All amebae were maintained axenically
in TYI-S-33 medium (8). E. histolytica was cultured at 36°C,
and the other Entamoeba isolates were cultured at 24°C.
Amebae were harvested by chilling cultures in ice water for
10 min, collecting the amebae by centrifugation at 275 x g
for seven min at 4°C, and washing them twice with phos-
phate-buffered saline no. 8 (K2HPO4, 3.7 g; KH2PO4, 1.1 g;
NaCl, 9.5 g; distilled H2O to 1,000 ml; pH 7.2; 360 mosmolV
kg). The washed cells were suspended in lysis buffer (20 mM
Tris chloride, pH 7.5; 2 mM phenylmethylsulfonyl fluoride;
5 mM p-chloromercuribenzoate; 100 ,ug of leupeptin per ml)
to give 2.5 x 106 cells per ml. The suspension was incubated
on ice for 30 min and disrupted by sonication for 30 s to give
whole-cell lysate antigen.
Hybridoma cell lines were generated by fusing
P3x63.Ag8.653 myeloma cells with spleen cells from hyper-
immunized mice (14, 27). Mice were immunized alternately
with purified plasma membrane (1) and whole cells. Approx-
imately 106 cells wee used for each immunization. The
hybridoma line 2D7.10 was expanded, and the ascitic fluid
was generated by injecting 5 x 106 hybridoma cells intraper-
itoneally into pristane-primed BALB/c mice. The antibodies
were stored at -70°C.
Antigen-coated wells (5 ,ug per well) were treated with 50
RI of 1.5-mg/ml trypsin for 30 min at room temperature. The
reaction was stopped by adding an equal amount of trypsin
inhibitor. Controls had either no trypsin or trypsin plus
trypsin inhibitor added together.
Sodium-m-periodate-mediated modification of sugar resi-
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dues was carried out essentially as described previously (31).
Periodate concentrations ranging from 1 to 50 mM were
added to 10 ,ug of whole E. histolytica lysate coated on
microtiter plates. Oxidation was carried out in 0.1 M sodium
acetate buffer, pH 4.5, in the dark at room temperature for 30
min. The reaction was stopped by adding 50 ,ul of 0.02 M
sodium sulfite, and the plate was washed twice with phos-
phate-buffered saline.
Enzyme-linked immunosorbent assay (ELISA) was car-
ried out essentially as previously described (11). Briefly, E.
histolytica lysate at 5 ,ug per well was used to coat 96-well
microtiter plates (Dynatech Laboratories, Inc., Chantilly,
Va.). After being blocked with gelatin, the antigen-coated
wells were incubated with monoclonal antibody 2D7.10. A
horseradish peroxidase-based biotin-streptavidin system and
o-phenylene diamine as the color reagent were used for
quantitation of bound 2D7.10 as recommended by the man-
ufacturer (Bethesda Research Laboratories, Inc., Gaithers-
burg, Md.). Color intensity was estimated by measuring
optical density at 492 nm.
The polypeptides were separated in 10% polyacrylamide
gels according to the method of Laemmli (15). After separa-
tion, the gels were either stained in 0.125% Coomassie
brilliant blue R250 or transferred to nitrocellulose paper
electrophoretically (31). Gels were stained with Coomassie
brilliant blue after transfer to ascertain completion of trans-
fer. Molecular weights were determined by using prestained
molecular weight markers (Bio-Rad Laboratories, Rich-
mond, Calif., or Sigma Chemical Co., St. Louis, Mo.). The
blot was probed with 2D7.10, and reactive antigens were
detected with goat anti-mouse immunoglobulin and conju-
gated to alkaline phosphatase. Color development utilized
5-bromo-4-chloro-3-indolyl phosphate and p-Nitro Blue Tet-
razolium as substrates. All protein concentrations were
determined with the BCA reagent (Pierce Chemical Co.,
Rockford, Ill.).
Hybridoma lines were screened for isolate- and species-
specific antibodies by indirect ELISA. Antibodies reacting
with E. histolytica isolates, but not other Entamoeba spe-
cies, were further characterized. One monoclonal antibody,
2D7.10 (y2b isotype), showed some isolate specificity. Rep-
resentative assays are shown in Fig. 1. Table 1 summarizes
all the studies. The 2D7.10 antigen was found to be present
only in E. histolytica and not in other Entamoeba isolates
tested. It was not detected in two (200:NIH and Rahman) of
the nine E. histolytica isolates studied.
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TABLE 1. E. histolytica and other Entamoeba isolates used in these studies
Strain Host Clinical Zymodeme Reference Reactivity withdiagnosis' 2D7.10
E. histolytica Schaudinn
200:NIH Human D II 6
HM-1:IMSS, cl 6 Human D II 9 +
Rahman, cl 1 Human NDAC II 10
KCG:0986:11 Human NDAC Ilb +
KCG:1287:16 Human NDAC lIb +
SAW 1734 R cl AR Human A IIb 20 +
HB-301:NIH, cl 1-6-7 Human D II 6 +
HK-9, cl 2 Human D II 6 +
HI-1295:AIIMS Human NDAC II 18 +
Other Entamoeba isolates
E. histolytica-like Laredo Human A 6
E. invadens Rodhain 165, cl 3 Terrapin 12
E. moshkovskii Tshalaia FIC Sewage effluent 7
a Classified according to report of a World Health Organization expert committee, W.H.O. Tech. Rep. Ser. 1969, no. 421. D, Dysentery; NDAC, nondysenteric
amebic colitis; A, asymptomatic.
b Zymodeme pattern changed from nonpathogenic to pathogenic during the process of axenization.
In order to determine the molecular size of the antigen
recognized by 2D7.10, Western blot analysis was carried out
(30). Results of the experiment are shown in Fig. 2. On
HM-1:IMSS antigen, a number of broad bands were seen
(lane 9). No reactivity was observed in an E. histolytica-like
ameba, Laredo strain (lane 5). Molecular weights of the
antigens recognized by the antibody varied. All isolates
tested showed a similar diffuse pattern; however, both the
KCG strains had extra bands (lanes 6 and 7) compared with
both HK-9 (lane 8) and HM-1 strains.
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FIG. 1. ELISA of different isolates of E. histolytica to determine
specificity of 2D7.10. Whole-cell lysates, prepared as described in
the text, were used as antigens in microtiter plate-based ELISA.
Bound antibody was detected using a biotin-streptavidin system.
Antigens were used in different concentrations ranging from 10 to
0.625 1Lg. Symbols: 0, HM-1:IMSS with 2D7.10; 0, HM-1:IMSS
with control ascites; A, Rahman with 2D7.10; A, Rahman with
control ascites; l, KCG:1287:16 with 2D7.10; *, KCG:1287:16 with
control ascites.
In order to determine the nature of the epitope recognized
by 2D7.10, the sensitivity of the antigen toward proteolytic
cleavage and periodate-mediated oxidation was studied.
Treatment of antigen with trypsin (up to 1.5 mg/ml) had no
effect on 2D7.10 reactivity as determined by ELISA (Fig.
3a). The 2D7.10 antigen is sensitive to periodate. Increasing
periodate concentrations lead to increased loss of antigenic-
ity. At 50 mM periodate, 91% of antigenicity is lost (Fig. 3b).
Monoclonal antibodies reported to date mainly recognize
determinants present in all E. histolytica (22, 29). Antibodies
which recognize determinants correlating with amebal isoen-
zyme patterns have also been reported (28). To our knowl-
edge, this is the first report of an antibody that can distin-
guish among isolates of E. histolytica belonging to the same
zymodeme (II, the most common pathogenic zymodeme).
Western blot analysis of E. histolytica strains with 2D7.10
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FIG. 2. Western blot analysis of different isolates of E. histolyt-
ica. Total cell lysates of the following isolates were resolved in
sodium dodecyl sulfate-10o polyacrylamide gel electrophoresis.
(A) Coomassie blue staining of gels; (B) enzyme immunostaining of
2D7.10-reactive antigens after electrophoretic transfer. Antibody
was used at a dilution of 1:5,000. Lanes 4 and 9, HM-1:IMSS; lanes
3 and 8, HK-9; lanes 2 and 7, KCG:1287:16; lanes 1 and 5, E.
histolytica-like ameba, Laredo strain; lane 6, KCG:0986:11. The
molecular weight standards (in thousands) are indicated by arrow-
heads.
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FIG. 3. Effect of proteolytic enzyme trypsin and sodium-m-periodate. Whole-cell lysate of HM-1:IMSS was coated on microtiter plates
at 10 ,ug per well. Proteolysis was carried out on antigen-coated wells as described in the text. Trypsin was allowed to react for 30 min, and
the reaction was stopped by adding trypsin inhibitor. Treated antigen was then probed with 2D7.10. (a) ELISA showing effect of trypsin on
2D7.10 antigen. Symbols: A, trypsin control, that is, enzyme and inhibitor added together with 2D7.10; 0, trypsin control with human
immune sera; A, trypsin digestion, plus human immune sera; O, trypsin digestion, plus 2D7.10. (b) Treatment with increasing concentrations
of periodate. Cell lysate at 10 ,ug per well was coated on microtiter plates, and concentrations of periodate ranging from 1 to 50 mM were
added. Treatment was carried out as described in the text.
showed numerous bands extending from 30 to 200 kilodal-
tons. These different bands were not due to degradation of
the antigens, because a number of different protease inhibi-
tors were used in preparation of the lysate. In addition, the
similar pattern obtained at all times also indicated that
multiplicity of bands may be an inherent characteristic of the
antigen. A similar pattern has also been observed with
antibodies recognizing a carbohydrate epitope of glycopro-
teins of neuronal cells (21). It is likely that a common epitope
present in different molecules may give rise to a similar
pattern (16, 21). The difference in the Western blot pattern
between the KCG strains and strains HM-1:IMSS and HK-9
may reflect the physiological changes in the cell brought
about by changes in isoenzyme patterns induced during the
process of axenization (20); however, we have to analyze
more such strains before we can make definitive conclu-
sions. The difference in Western blot patterns may be due to
the addition of a common epitope to different polypeptides.
The experiments with periodate and proteolytic enzymes
suggest that the antigenic determinant may be a carbohy-
drate molecule. The carbohydrate moiety is not a neuraminic
acid derivative, because mild periodate oxidation (1.0 mM)
has a nominal effect on antigenicity (31).
The importance of carbohydrates in virulence has been
amply demonstrated with E. histolytica (19, 24). It now
seems certain that the bacterial flora associated with the
amebae in vitro influences their pathogenicity. Molecular
mediators of ameba-bacterium interaction appear to be car-
bohydrates, especially the mannose-containing sugars (19).
Recognition of target epithelial cells by E. histolytica is also
mediated through interaction with specific sugars on the
target cell (24). These studies indicate that sugars play an
important role in the virulence of E. histolytica. Our finding
that E. histolytica strains can be distinguished on the basis of
altered carbohydrate antigens may have relevance in the
studies on the mechanism of pathogenicity of the ameba.
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